MarketWatch

Strong Signal for Investors: VR LIFE and H2 Global Group Validate the Value of European MedTech Innovation

H2 Global Group is strengthening its position as a European technology group connecting capital with clinically validated healthcare innovations. A prime example is VR LIFE and its flagship ...
IBTimes UK

Military and First Responders in Focus: European MedTech Innovation with Japanese Roots Sends Strong Signal to Investors and Partners

PRAGUE, CZECH REPUBLIC. April 10th, 2026 – The valuation growth of VR LIFE, strong clinical traction, and upcoming US market entry are accelerating the strategy of H2 Global Group. Their platform ...
Columbus Dispatch

U.S. Military and First Responders in Focus: European MedTech Innovator with Japanese Roots Signals Value to Investors

VR LIFE’s $650K seed round, SÚKL-approved clinical trial, and growing military interest strengthen H2 Global Group’s $80M pre-money U.S. expansion strategy. We are opening doors for American, European ...
Amarillo Globe-News

Strong Signal for Investors and Partners: H2 Global Group and VR LIFE Validate the Value of European MedTech Innovation

PRAGUE, CZECH REPUBLIC, April 7, 2026 /EINPresswire.com/ — European MedTech innovator H2 Global Group is accelerating its expansion into the United States and ...